Trichomonas vaginalis epidemiology: Parameterising and analysing a model of treatment interventions

Sexually Transmitted Infections

Volumn 76, Issue 4, 2000, Pages 248-256

  Bowden, Francis J ^a,b   Garnett, Geoffrey P ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CANBERRA HOSPITAL   (Australia)

Author keywords

HIV; Mathematical modelling; Screening; Syndromic management; Trichomonas vaginalis; Trichomoniasis

Indexed keywords

METRONIDAZOLE; NITROIMIDAZOLE;

ARTICLE; CLINICAL FEATURE; DISEASE COURSE; ENDEMIC DISEASE; FEMALE; HEALTH CARE ACCESS; HUMAN; INFECTION CONTROL; INFECTION RISK; MALE; MATHEMATICAL MODEL; PARASITE PREVALENCE; PARASITE TRANSMISSION; PRIORITY JOURNAL; SCREENING; TREATMENT OUTCOME; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

ANIMALS; FEMALE; HUMANS; MALE; MASS SCREENING; MODELS, BIOLOGICAL; PREVALENCE; SEX FACTORS; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS;

EID: 0033811563     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.76.4.248     Document Type: Article

References (69)

1. 1 World Health Organization. Global prevalence and incidence of selected curable sexually transmitted diseases: overview and estimates. WHO/GPA/STD/95. Geneva: WHO, 1995.
2. 2 Petrin D, Delgaty K, Bhatt R, et al. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998,11:300-17.
3. 3 Heine P, McGregor JA. Trichomonas vaginalis: a reemerging pathogen. Clin Obstet Gynecol 1993;36:137-44.
4. 4 Cotch MF, Pastorek JG, 2nd, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997;24:353-60.
5. 5 ter Meulen J, Mgaya HN, Chang-Claude J, et al. Risk factors for HIV infection in gynaecological inpatients in Dar es Salaam, Tanzania, 1988-1990. East Afr Med J 1992;69: 688-92.
6. 6 Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993;7:95-102.
7. 7 Ghys PD, Diallo MO, Ettiegne-Traore V, et al. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis 1995;172:1371-4.
8. 8 Sorvillo F, Kerndt P. Trichomonas vaginalis and amplification of HIV-1 transmission [letter]. Lancet 1998,351:213-4.
9. 9 Peterson P. Trichomonas vaginalis vaginitis. A comparative study of treatment and incidence. Am J Obstet Gyn 1938;35:1004-9.
10. 10 Feo LG. The incidence and significance of Trichomonas vaginalis in the male. Am J Tropical Med 1943;24:195-8.
11. 11 Whittington MJ. The occurrence of Trichomonas vaginalis in semen. J Obstet Gynaecol Brit Emp 1951;58:615-19.
12. 12 Coutts WE, Vargas-Salazar R, Silva-Inzunza E, et al. Trichomonas vaginalis infection in the male. BMJ 1955;ii: 885-89.
13. 13 Buxton CL, Weinman D, Johnson C. Epidemiology of Trichomonas vaginalis vaginitis. Obstet Gynec 1958;12:699-702.
14. 14 Burch TA, Rees CW, Reardon LV. Epidemiological studies on human trichomoniasis. Am J Trop Med Hyg 1959;8:312-18.
15. 15 Wisdom AR, Dunlop EMC. Trichomoniasis. Study of the disease and its treatment. Br J Vener Dis 1965;41:90-6.
16. 16 Zigas V. An evaluation of trichomoniasis in two ethnic groups in Papua New Guinea. Sex Transm Dis 1977;4:63-5.
17. 17 Tapsall JW, Puglisi J, Smith DD. Trichomonas vaginalis infections in Sydney: laboratory diagnosis and prevalence. Med J Aust 1979;1:193-4.
18. 18 Wilson A, Ackers JP. Urine culture for the detection of Trichomonas vaginalis in men. Br J Vener Dis 1980;56:46-8.
19. 19 Mirza NB, Nsanze H, LJ DC, Piot P. Microbiology of vaginal discharge in Nairobi, Kenya. Br J Vener Dis 1983;59: 186-8.
20. 20 Hardy PH, Hardy JB, Nell EE, et al. Prevalence of six sexually transmitted disease agents arising in pregnant inner-city adolescents and pregnancy outcome. Lancet 1984;2: 333-7.
21. 21 Mabey DC, Lloyd-Evans NE, Conteh S, et al. Sexually transmitted diseases among randomly selected attenders at an antenatal clinic in The Gambia. Br J Vener Dis 1984;60: 331-6.
22. 22 Wolner-Hanssen P, Kreiger JN, Stevens C, et al. Clinical manifestations of vaginal trichomoniasis. JAMA 1989;261: 571-6.
23. 23 O Farrell N, Hoosen AA, Kharsany AB, et al. Sexually transmitted pathogens in pregnant women in a rural South African community. Genitourin Med 1989;65:276-80.
24. 24 Lefevre JC, Lepargneur JP, Bauriaud R, et al. Clinical and microbiologic features of urethritis in men in Toulouse, France. Sex Transm Dis 1991;18:76-9.
25. 25 Saxena SB, Jenkins RR. Prevalence of Trichomonas vaginalis in men at high risk for sexually transmitted diseases. Sex Transm Dis 1991;18:138-42.
26. 26 Iyer SV, Deodhar L, Gogate A. Microbiological evaluation of female patients in STD clinics. Indian J Med Res 1991;93:95-7.
27. 27 Stefanik M, Rychna K, Valkoun A. Microbial causative agents of male urethritis. J Hyg Epidemiol Microbiol Immunol 1992;36:111-8.
28. 28 Krieger JN, Verdon M, Siegel N, et al. Risk assessment and laboratory diagnosis of trichomoniasis in men. J Infect Dis 1992;166:1362-6.
29. 29 Anosike JC, Onwuliri CO, Inyang RE, et al. Trichomoniasis amongst students of a higher institution in Nigeria. Appl Parasitol 1993;34:19-25.
30. 30 Cronje HS, Joubert G, Muir A, et al. Prevalence of vaginitis, syphilis and HIV infection in women in the Orange Free State. S Afr Med J 1994;84:602-5.
31. 31 Borchardt KA, al-Haraci S, Maida N. Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch TV test. Genitourin Med 1995;71: 405-6.
32. 32 Tabrizi SN, Paterson B, Fairley CK, et al. A self-administered technique for the detection of sexually transmitted diseases in remote communities. J Infect Dis 1997;176:289-92.
33. 33 Heine RP, Wiesenfeld HC, Sweet RL, et al. Polymerase chain reaction analysis of distal vaginal specimens: a less invasive strategy for detection of Trichomonas vaginalis. Clin Infect Dis 1997;24:985-7.
34. 34 Klouman E, Masenga EJ, Klepp KJ, et al. HIV and reproductive tract infections in a total village population in rural Kilimanjaro, Tanzania: women at increased risk. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:163-8.
35. 35 Waghorn DJ, Tucker PK, Chia Y, et al. Collaborative approach to improve the detection and management of trichomoniasis in a low prevalence district. Int J STD AIDS 1998;9:164-7.
36. 36 el Seoud SF, Abbas MM, Habib FS. Study of trichomoniasis among Egyptian male patients. J Egypt Soc Parasitol 1998;28:263-70.
37. 37 Passey M, Mgone CS, Lupiwa S, et al. Community based study of sexually transmitted diseases in rural women in the highlands of Papua New Guinea: prevalence and risk factors. Sex Transm Inf 1998;74:120-7.
38. 38 Bowden FJ, Paterson BA, Mein J, et al. Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, and Neisseria gonorrhoeae in indigenous women in Northern Australia. Sex Transm Inf 1999;75:431-4.
39. 39 Ipsen J, Feigl P. A biomathematical model for prevalence of Trichomonas vaginalis. Am J Epidemiol 1970;91:175-84.
40. 40 Hethcote HW, Yorke JA. Gonorrhea transmission dynamics and control. Berlin: Springer-Verlag, 1984.
41. 41 Garnett GP, Mmertz KJ, Finelli L, et al. The transmission dynamics of gonorrhoea: modelling the reported behaviour of infected patients from Newark, New Jersey. Philos Trans R Soc Lond B Biol Sci 1999;354:787-97.
42. 42 Garnett GP, Anderson RM. Contact tracing and estimation of sexual mixing patterns. The epidemiology of gonococcal infections. Sex Transm Dis 1993;20:181-91.
43. 43 Catterall RD, Nicol CS. Is trichomonal infestation a venereal disease? BMJ 1960;i:1177-9.
44. 44 Catterall RD. Diagnosis and treatment of trichomonal urethritis in men. BMJ 1960;i:113-15.
45. 45 Whitington MJ. Epidemiology of infections with Trichomonas vaginalis in the light of improved diagnostic methods. Br J Vener Dis 1957;33:80-91.
46. 46 Lanceley F, McEntegart MG. Trichomonas vaginalis in the male. The experimental infection of a few volunteers. Lancet 1953;i:668-71.
47. 47 Drummond AC. Trichomonas infestation of the prostate gland. Am J Surg 1936,31:98-103.
48. 48 Watt L, Jennison RF. Incidence of Trichomonas vaginalis in marital partners. Br J Vener Dis 1960;36:163-6.
49. 49 Krieger JN, Verdon M, Siegel N, et al. Natural history of urogenital trichomoniasis in men. J Urol 1993;149:1455-8.
50. 50 Madico G, Quinn TC, Rompalo A, et al. Diagnosis of trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol 1998;36:3205-10.
51. 51 Feo LG. Trichomonas vaginalis infection in postmenopausal women. Am J Obstet Gynecol 1956;72:1335-9.
52. 52 Paterson BA, Tabrizi SN, Garland SM, et al. The tampon test for trichomoniasis: a comparison between conventional methods and a polymerase chain reaction for Trichomonas vaginalis in women. Sex Transm Inf 1998;74:136-9.
53. 53 Paxton LA, Kiwanuka N, Nalugoda F, et al. Community based study of treatment seeking among subjects with symptoms of sexually transmitted disease in rural Uganda. BMJ 1998;317:1630-1.
54. 54 Latif AS, Mason PR, Marowa E. Urethral trichomoniasis in men. Sex Transm Dis 1987;14:9-11.
55. 55 Weston TET, Nicol CS. Natural history of trichomonal infection in males. Br J Vener Dis 1963;39:251-7.
56. 56 Wilcox RR. Epidemiological aspects of trichomoniasis. Br J Vener Dis 1960;36:167-74.
57. 57 Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis nf complex models of disease transmission: an HIV model, as an example. Int Stat Rev 1994;62:229-43.
58. 58 Chan MS. The consequences of uncertainty for the prediction of the effects of schistosomiasis control programmes. Epidemiol Infect 1996;117:537-50.
59. 59 JMP statistics [program]. 3.2.1 version: SAS Institute, 1996.
60. 60 Gulmezoglu AM, Garner P. Trichomoniasis treatment in women: a systematic review. Trop Med Int Health 1998;3: 553-8.
61. 61 Passey M, Mgone CS, Lupiwa S, et al. Screening for sexually transmitted diseases in rural women in Papua New Guinea: are WHO therapeutic algorithms appropriate for case detection? Bull World Health Organ 1998;76:401-11.
62. 62 Blower SN, Small PM, Hopewell PC. Control strategies for tuberculosis epidemics:new models for old problems. Science 1996;273:497-500.
63. 63 Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units [see comments]. N Engl J Med 2000; 342:534-40.
64. 64 Krieger JN. Trichomoniasis in men: old issues and new data. Six Transm Dis 1995;22:83-96.
65. 65 Krieger JN, Alderete JF. Trichomonas vaginalis and trichomoniasis. In: Holmes KK SP, Mardh PA, Lemon SA, Stamm WE, Piot P, Wasserheit JN, eds. Sexually transmitted diseases. New York: McGraw-Hill, 1999.
66. 66 DeHovitz JA, Kelly P, Feldman J, et al. Sexually transmitted diseases, sexual behavior, and cocaine use in inner-city women. Am J Epidemiol 1994;140:1125-34.
67. 67 Sorvillo F, Kovacs A, Kerndt P, et al. Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles County, California: implications for HIV prevention. Am J Trop Med Hyg 1998;58:495-500.
68. 68 Mascall N. Some reflections on the Trichomonas vaginalis. Br J Vener Dis 1954;30:156-62.
69. 69 Rodin P, King AJ, Nicol CS, et al. Flagyl in the treatment of trichomoniasis. Br J Vener Dis 1960;36:147-51.s